FDA Adverse Event Malfunction Summary report: N

ASCENSIA BREEZE2 TEST STRIPS (50)

MDR report key: 1163658 · Received September 9, 2008

Report

Report Number
1826988-2008-01006
Event Type
Malfunction
Date Received
September 9, 2008
Date of Event
August 19, 2008
Report Date
August 19, 2008
Manufacturer
BAYER HEALTHCARE, LLC
Product Code
NBW
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

THE CUSTOMER TESTED HIS BLOOD GLUCOSE USING HIS BREEZE2 METER AND RECEIVED A READING OF 216 MG/DL. HE RETESTED USING ANOTHER METER AND RECEIVED A READING OF 98 MG/DL. THE DIFFERENCE BETWEEN THE READINGS FALLS IN THE "C" ZONE OF THE PARKES ERROR GRID, MAKING THE DIFFERENCE CLINICALLY SIGNIFICANT. WHILE TROUBLESHOOTING, THE CUSTOMER PERFORMED CONTROL TESTS AND RECEIVED A RESULT OF 170 MG/DL. THE NORMAL CONTROL RANGE WAS 90-123 MG/DL. NO ADVERSE EVENTS WERE ALLEGED. THE TEST STRIPS ARE TO BE RETURNED FOR EVALUATION. REPLACEMENT TEST STRIPS WERE SENT TO THE CUSTOMER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASCENSIA BREEZE2 TEST STRIPS (50) BLOOD GLUCOSE TEST STRIPS NBW BAYER HEALTHCARE, LLC 1468 1T5230AA

Patients

Seq Age Sex Outcome Treatment
1 UNK